A

s more lawmakers support importation in response to the rising cost of medicines, four former commissioners of the US Food and Drug Administration wrote an open letter to Congress on Thursday to warn that the idea is “a complex and risky approach.”

The former agency heads argue that routine importation is “likely to harm patients and consumers and compromise the carefully constructed system that guards the safety of our nation’s medical products.” And they maintain that the ‘closed distribution system’ overseen by the FDA ensures that good manufacturing practices are followed and the quality of the supply chain is protected.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our
Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine — delivered straight to your inbox every weekday afternoon.